PRWeb The Leader Press Release Distribution

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for June 8, 2005 Subscribe to this News Feed    
 

Progenitor Cell Therapy, LLC Welcomes Dr. Onyenoha Chukwumerije as Vice President, Quality Assurance

Progenitor Cell Therapy, LLC is pleased to announce that Dr. Onyenoha Chuck" Chukwumerije has joined the Companys Executive Management Team as Vice President, Quality Assurance.

Hackensack, NJ (PRWEB) June 8, 2005 -- Dr. Chuck is a pharmaceutical manufacturing executive with expertise in quality control/quality assurance operations, lean manufacturing, process improvement, regulatory compliance, strategic partnering and global outsourcing. Prior to joining PCTs team of cell therapy specialists, Dr. Chuck was the Executive Director responsible for External Manufacturing and Supplier Quality at Purdue Pharma.

He is a member of the American Society for Quality, the International Pharmaceutical Excipients Council-Americas and the International Society for Pharmaceutical Engineering. Dr. Chuck was also the past Chair of the Dissolution Technical Working Group of PhRMA, and currently serves on the Editorial Advisory Board for Pharmaceutical Formulation and Quality.

We are pleased to welcome Dr. Chuck to our Senior Management team, and we look forward to his leadership and stewardship of our quality systems", said Robert A. Preti, PhD, PCTs President & Chief Scientific Officer. Chucks strong track record in building regulatory and quality compliance in internal operations, as well as pharmaceutical outsourcing, represents a perfect fit with our business model."

Dr. Chuck received his Doctor of Philosophy degree from St. Johns University in New York.

About Progenitor Cell Therapy, LLC
Progenitor Cell Therapy, LLC is the leading contract manufacturing platform company serving the developing cell therapy industry. PCT provides for the collection, manufacture, storage and redistribution of human cells for therapeutic purposes through a nationwide network, operated in compliance with current Good Manufacturing Practices (cGMP). For more information, visit www.progenitorcelltherapy.com.

Contact:
George Goldberger
Chief Business Officer
Progenitor Cell Therapy, LLC
(201) 883-5314
ggoldberger@progenitorcell.net

# # #

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
George Goldberger
Progenitor Cell Therapy
201-883-5314
Email us Here
ATTACHED FILES

PCT

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.